OncoMatch/Clinical Trials/NCT07022470

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Is NCT07022470 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for cervical cancers.

Phase 2RecruitingStanford UniversityNCT07022470Data as of May 2026

This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.

Check if I qualify

Extracted eligibility criteria

Cancer type

Cervical Cancer

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Prior therapy

Cannot have received: radiation therapy

Prior radiation to the pelvis > 3 months ago

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

Stanford University · Palo Alto, California

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify